P
Provivi
A groundbreaking science-based company creating scalable, safer insect control technology that will improve the quality of life for all humans and our world
About Provivi
Provivi operates in the agricultural chemicals sector, providing farmers with alternatives to traditional insecticides. The company was founded in 2013 by Dr. Pedro Coelho, Dr. Peter Meinhold, and 2018 Nobel laureate in Chemistry, Dr. Frances Arnold. Dr. Arnold, a professor at Caltech, pioneered methods of directed evolution to create new proteins. Dr. Coelho holds a Ph.D. in Chemistry from Caltech and a Master's from the University of Oxford, with a career focused on developing pheromone-based pest control solutions.
The core of Provivi's business is the development and production of insect pheromones for mating disruption. This preventative method uses dispensers that release species-specific pheromones into a field, which confuses male insects and disrupts their ability to find mates, thereby reducing the pest population in the next generation. This approach avoids harming non-target organisms, including beneficial insects and pollinators. The company's technology, based on biocatalysis and fermentation, is designed to significantly lower the manufacturing cost of pheromones, making them economically viable for large-scale row crops like corn, rice, and soy.
Provivi's product line, under names like Pheron®, includes solutions targeting major agricultural pests such as the Fall Armyworm and the Yellow Stem Borer. Products like "Provivi FAW™" and "Pherogen® Granulo FAW" have received regulatory approval in markets including Mexico and Brazil. The company offers its products in various formulations, such as dispensers for smaller farms and liquid sprays for application with existing farm equipment on larger operations. Its business model involves both direct-to-farmer sales and strategic partnerships with major agricultural companies like Syngenta and Godrej Agrovet for distribution and commercialization in global markets, including Indonesia, India, and Mexico.
Since its inception, Provivi has raised over $230 million in funding across multiple rounds. Key investors include the Gates Foundation, BASF Venture Capital, Kairos Ventures, and Temasek. This capital has supported product development, regulatory approvals, and commercial launches. For instance, a 2022 pilot program in Guanajuato, Mexico, demonstrated the effectiveness of its mating disruption technique on corn crops. After its first commercial year in Mexico, the company reported serving over 1,000 growers across 100,000 hectares.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2013
- Headquarters
- Santa Monica, United States
- Employees
- 84
- Open positions
- None listed
- Dealroom signal
- 64.5/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, Pest Control, Biopesticides, Chemical, Synthetic Biology, Spinout, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| CONVERTIBLEOther financing | Oct 2021 | $0 | — | Undisclosed | — |
| SERIES COther financing | Feb 2021 | $10M | $228M | Bill & Melinda Gates Foundation | — |
Growth signals
Latest recorded traffic for Provivi is 2.3K monthly website visits, up 15% over the last three months. Provivi's team declined 1.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
ArakionAI-powered bioinsecticides from arachnid venom peptides |
Dover, United States | Operational | 4 | $250K | $1M |
SOLASTA BioNature-inspired, peptide-based bioinsecticides for targeted pest control |
Glasgow, United Kingdom | Operational | |||
AgriodorThe biocontrol solution against pests |
Rennes, France | Operational | |||
BiotalysProtein-based biocontrol solutions for sustainable crop protection |
Ghent, Belgium | Operational | |||
BioPheroProvides low-cost bio-based pheromones for pest management |
Copenhagen, Denmark | Acquired | |||
VestaronDedicated to improving the safety, efficacy, and sustainability of crop protection through migration from chemical pesticides to biological peptides |
Kalamazoo, United States | Operational | |||
Molecular AttractionEco-friendly bio-attractants for vector-borne disease control |
Solna kommun, Sweden | Operational | |||
Solar FoodsIntroducing a game-changing natural protein for the global food industry |
Helsinki, Finland | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series A4 investors entered at this stage
Kairos Ventures
Spruce Capital Partners
DuPont
Kairos
Series B and later5 investors entered at this stage
Temasek
Pontifax AgTech
Tybourne Capital Management
Vivo Capital
Bill & Melinda Gates Foundation
Other known investors2 additional known investors
Caltech, California Institute of Technology
Massachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Provivi on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Provivi’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







